Translating Expanding Therapeutic Choice into Practical CKD Treatment Algorithms to Guide the Next Standard of Care

2:00 pm - Thursday 18th March 2027

  • Determining which treatment to initiate, layer or switch according to disease mechanism and stage
  • Integrating efficacy, safety, cardiovascular risk, patient preference and access into decision-making
  • Identifying the evidence still required before precision sequencing becomes routine clinical practice

Speakers:

Executive Director - Medical
Bayer